摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-(benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl)phenyl acetate | 1234478-57-9

中文名称
——
中文别名
——
英文名称
3-(4-(benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl)phenyl acetate
英文别名
DBP-5;[3-[4-(1,3-Benzothiazol-2-yl)-1-phenylpyrazol-3-yl]phenyl] acetate
3-(4-(benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl)phenyl acetate化学式
CAS
1234478-57-9
化学式
C24H17N3O2S
mdl
——
分子量
411.484
InChiKey
NXEXILYRFQJVCK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.4
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.04
  • 拓扑面积:
    85.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway
    摘要:
    3-(4-(Benzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate (DPB-5) is a synthetic benzothiazole derivative. In the present study, we revealed that DPB-5 had strong cytotoxicity to induce cell apoptosis, which was mediated by ROS. And DPB-5 was more cytotoxic toward hepatoma cells than toward normal hepatic cells, which was resulted from the greater susceptibility of the malignant cells to ROS. DBP-5 caused massive ROS accumulation and GSH decrease. which lead to MMP disruption, caspase activation and finally induced cell apoptosis. Additionally, rotenone, an inhibitor of mitochondria electron transport system, effectively blocked the ROS elevated effect of DPB-5, which suggested that DPB-5-induced ROS generated from the mitochondria. Further studies showed that DPB-5-induced cell apoptosis through caspases-cascade, but failed to activate caspase-9. Hence, we concluded that DPB-5-induced Hep G2 cells apoptosis via a ROS-mediated pathway which was caspase-dependent but did not rely on caspase-9 (C) 2009 Elsevier Ireland Ltd. All rights reserved.
    DOI:
    10.1016/j.cbi.2009.12.008
点击查看最新优质反应信息